Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 ARS Form ARS - Annual Report to Security Holders:
10/04/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/04/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: " "
08/17/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Reviva Reports Second Quarter 2023 Financial Results and Recent Business Highlights"
07/24/2023 8-K Quarterly results
05/05/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2023 8-K Quarterly results
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/30/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/30/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/30/2023 10-K Annual Report for the period ended December 31, 2022
03/30/2023 8-K Quarterly results
02/14/2023 SC 13G/A TANG CAPITAL PARTNERS LP reports a 10% stake in Reviva Pharmaceuticals Holdings, Inc.
01/04/2023 8-K Quarterly results
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 8-K Quarterly results
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2022 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
10/18/2022 EFFECT Form EFFECT - Notice of Effectiveness:
10/11/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/06/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2022 D Form D - Notice of Exempt Offering of Securities:
09/12/2022 SC 13D/A VEDANTA PARTNERS, LLC reports a 19.9% stake in Reviva Pharmaceuticals Holdings, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy